Cell Culture Instrument Sales

Cell Culture Instrument Sales Market Outlook

The global cell culture instrument sales market is projected to reach approximately USD 6.72 billion by 2035, growing at a compound annual growth rate (CAGR) of around 10.5% during the forecast period. This growth is spurred by the increasing demand for biopharmaceuticals, rising investments in biotechnology and pharmaceuticals, and the accelerating trend towards personalized medicine. Furthermore, advancements in cell culture technologies and the growing prevalence of chronic diseases are also significant contributors to the market growth. The ongoing research and development activities in the domains of cancer treatment and stem cell research are expected to further drive the demand for sophisticated cell culture instruments. Moreover, the increasing emphasis on innovative research methodologies is facilitating the enhancements in cell culture practices, thereby contributing to the market’s expansion.

Growth Factor of the Market

The growth of the cell culture instrument sales market is primarily driven by the escalating need for advanced research methodologies in life sciences. As the biopharmaceutical sector expands, there is a growing requirement for high-quality cell culture products that can meet regulatory standards and yield consistent results. Additionally, the increase in research funding by government and private entities is promoting innovations leading to new product development. The rising incidence of diseases such as cancer, diabetes, and neurodegenerative disorders has heightened the focus on research initiatives to develop effective treatments, thus propelling the demand for cell culture instruments. Moreover, the shift towards automation in laboratories is enhancing the efficiency and throughput of cell culture processes, which is also a substantial growth factor contributing to the market evolution. The burgeoning interest in regenerative medicine and tissue engineering is playing a crucial role in driving market dynamics, as researchers increasingly rely on cell culture systems for developing therapeutic solutions.

Key Highlights of the Market

• The global cell culture instrument market is set to grow at a CAGR of 10.5% from 2025 to 2035.
• The bioreactors segment is anticipated to hold a significant share due to their pivotal role in bioprocessing.
• North America is expected to dominate the market owing to the presence of advanced research facilities and high healthcare expenditure.
• Online sales channels are gaining traction, with increasing convenience for researchers and laboratories.
• The growing focus on personalized medicine is creating new opportunities for cell culture technologies.

By Product Type

Incubators:

Incubators are essential components in cell culture, providing an environment conducive to cell growth by maintaining optimal temperature, humidity, and CO2 levels. The increasing adoption of incubators in research laboratories and biopharmaceutical companies is a significant trend, as they are critical for culturing mammalian cells, which require very specific conditions. Modern incubators come equipped with advanced features such as touchscreen interfaces, programmable settings, and real-time monitoring systems that enhance usability and ensure precise conditions for cell growth. The demand for incubators is particularly pronounced in applications like cancer research and regenerative medicine, where precise environmental control is paramount for successful experiments. As bioprocessing technologies evolve, the capabilities of incubators are also advancing, further driving their adoption in various laboratory settings.

Centrifuges:

Centrifuges play a vital role in the cell culture process, particularly in the separation and isolation of cells and cellular components. They are widely utilized in applications such as cell harvesting, purification, and concentration. The market for centrifuges is expanding as researchers increasingly rely on them for efficient cell processing in applications like drug development and tissue engineering. Technological advancements are leading to the emergence of high-speed and automated centrifuges, which significantly improve the efficiency of cell culture workflows. Moreover, the increasing emphasis on high-throughput screening and the growing number of research initiatives in cell biology are also contributing to the growth of this segment. The diversity of centrifuge types—from bench-top to floor models—allows laboratories to choose equipment tailored to their specific needs, further driving market penetration.

Bioreactors:

Bioreactors are critical for large-scale cell culture, providing a controlled environment for cell proliferation and product formation. The cell culture instrument sales market is seeing significant growth in the bioreactor segment due to the increasing demand for biopharmaceuticals and vaccines. These instruments are designed to optimize conditions for cell growth, including nutrient delivery, pH control, and waste removal. The rise in biologics and personalized medicine has further propelled the demand for bioreactors capable of supporting complex cultures. With advances in single-use bioreactor technology, researchers are now able to conduct experiments with minimal risk of cross-contamination and easier scalability. This segment is also witnessing innovation with the integration of automation and real-time monitoring systems, enhancing efficiency and productivity in biomanufacturing processes.

Microscopes:

Microscopes are indispensable tools in the field of cell culture, enabling detailed observation and analysis of cellular structures and behaviors. The demand for advanced microscopy solutions, such as fluorescence and confocal microscopes, is growing as researchers require sophisticated imaging techniques to monitor live cell cultures and assess cellular responses to various treatments. The integration of digital imaging technologies is revolutionizing microscopy, allowing for high-resolution imaging and data analysis that are crucial for applications in cancer research and stem cell studies. As the need for precise visualization in cellular applications increases, the microscopy segment is expected to evolve, with innovative solutions aimed at enhancing user experience and experimental outcomes. The combination of microscopy with artificial intelligence for image analysis is also emerging as a key trend, enabling higher throughput and more robust data collection in cell culture studies.

Pipetting Instruments:

Pipetting instruments are fundamental in cell culture for accurate transfer and measurement of liquids, which is crucial in maintaining cell viability and experimental integrity. As laboratory automation continues to grow, the demand for precision and efficiency in pipetting has led to the development of advanced pipetting systems, including electronic pipettes and automated liquid handling systems. These innovations reduce human error, enhance reproducibility, and increase throughput in laboratory workflows, especially in large-scale experiments. The availability of various pipetting systems catering to different volumes and applications further supports the segment's growth. With a rising focus on standardizing laboratory procedures, the importance of reliable pipetting instruments is becoming more pronounced, ensuring that researchers can achieve consistent results in their cell culture experiments.

By Application

Cancer Research:

Cancer research is a key application area for cell culture instruments, as it provides essential insights into tumor behavior and therapy responses. Researchers rely on sophisticated cell culture techniques to study the proliferation, migration, and signaling pathways of cancer cells. The increasing prevalence of cancer globally has led to intensified research efforts for the development of new therapeutic strategies, driving the demand for advanced cell culture instruments. The ability to grow cancer cell lines under controlled conditions enables the testing of potential drugs and their effects, facilitating the discovery of more effective treatments. Moreover, the integration of organoid culture models is becoming popular in cancer research, providing more physiologically relevant conditions that are expected to enhance the predictive power of preclinical studies.

Drug Development:

The drug development process heavily relies on cell culture techniques for screening and testing potential therapeutic candidates. Cell culture instruments are critical for conducting preliminary studies to assess drug efficacy and safety. The increasing investment in pharmaceutical research and development is propelling the demand for innovative cell culture solutions that can streamline drug discovery processes. Automated cell culture systems are particularly gaining traction, enabling high-throughput screening of compounds and accelerating the overall development timeline. Furthermore, the growing emphasis on personalized medicine is driving the adoption of patient-derived cell cultures, which can provide more accurate predictions of individual patient responses to drugs. This trend is fostering an ecosystem where cell culture instruments play a pivotal role in advancing drug development, ensuring that therapies are tailored to meet specific patient needs.

Tissue Engineering:

Tissue engineering is an emerging field that heavily utilizes cell culture technologies to create biological substitutes for damaged tissues. The demand for cell culture instruments in this segment is growing as researchers seek to develop functional tissue constructs for regenerative medicine applications. The ability to culture cells in three-dimensional environments is critical for mimicking native tissue architecture and functionality. Advances in scaffold technology and bioreactor systems that support tissue engineering are further enhancing the capabilities of cell culture instruments in this sector. The synergistic use of cell culture with biomaterials is facilitating innovative approaches in tissue regeneration, leading to significant advancements in clinical applications. The need for reliable and versatile cell culture instruments in tissue engineering applications is crucial for developing effective therapies aimed at repairing or replacing damaged tissues.

Regenerative Medicine:

Regenerative medicine focuses on repairing or replacing damaged cells, tissues, or organs, heavily relying on cell culture technologies. The growth of this application area is driving the demand for sophisticated cell culture instruments that can support the differentiation and proliferation of stem cells. As research progresses, the ability to manipulate cell fate through controlled culture conditions is becoming increasingly important. Currently, innovations such as stem cell-derived organoids are revolutionizing the field, allowing researchers to study disease mechanisms and test new drugs in a more relevant biological context. The continuous advancements in bioreactor technology and the development of specialized culture media are enabling more rigorous research in regenerative medicine applications. Consequently, the cell culture instrument sales market is witnessing significant traction from the regenerative medicine sector, as it plays a vital role in the advancement of therapeutic solutions.

Stem Cell Research:

Stem cell research has become a cornerstone of modern biomedical research, relying heavily on advanced cell culture tools to study the properties and applications of stem cells. The ability to culture and differentiate stem cells into various cell types is crucial for understanding their potential in therapeutic settings. As interest in stem cell therapies continues to grow, the demand for specialized cell culture instruments that can support the unique requirements of stem cell research is on the rise. Instruments capable of providing optimal growth conditions and precise environmental control are essential for researchers working on regenerative therapies. Moreover, the integration of high-throughput technologies in stem cell research is enhancing the scalability and efficiency of experiments, allowing for more comprehensive studies on stem cell behaviors and applications. The segment is expected to grow significantly as new discoveries and innovations continue to emerge from ongoing stem cell research initiatives.

By Distribution Channel

Direct Sales:

Direct sales remain a prominent distribution channel for cell culture instruments, enabling manufacturers to engage directly with end-users. This channel allows for personalized service, ensuring that customers receive tailored solutions that meet their specific research needs. Direct sales representatives often provide valuable insights into the latest technologies and best practices, enhancing user experience and satisfaction. Moreover, direct engagement allows manufacturers to gather feedback and refine their products based on user requirements, thereby fostering innovation. The trend toward direct sales is supported by the increasing demand for customized cell culture solutions, as researchers seek instruments that can adapt to their unique experimental workflows.

Distributor Sales:

Distributor sales play a significant role in the cell culture instrument market, providing a broader reach and accessibility to various end-users. Distributors often have established networks and relationships within academic, pharmaceutical, and biotechnology sectors, facilitating the introduction of cell culture instruments to a wider audience. These sales channels allow manufacturers to leverage the expertise of distributors, who can provide technical support and training to end-users. Additionally, distributors frequently carry a diverse range of products, enabling researchers to find comprehensive solutions for their laboratory needs. The reliance on distributor sales is expected to remain strong, particularly in regions where direct manufacturer engagement is less feasible due to geographical challenges.

Online Sales:

Online sales have emerged as a rapidly growing distribution channel for cell culture instruments, driven by the increasing trend of e-commerce and digital transformation within the scientific community. Researchers appreciate the convenience and accessibility of purchasing instruments online, allowing them to compare products, read reviews, and make informed purchasing decisions from the comfort of their labs. The rise of online platforms is particularly beneficial for customers in remote or underserved regions, as they can access a wide range of products without the need for extensive travel. Furthermore, online sales channels are often coupled with detailed product information and customer support, enhancing the overall user experience. This trend is expected to continue as more laboratories embrace online solutions for their procurement processes.

Retail Sales:

Retail sales represent a more traditional distribution channel for cell culture instruments, allowing customers to view and purchase products in physical stores. Retail environments can offer hands-on experience with instruments, enabling researchers to assess the functionality and usability before making a purchase. While this channel has seen a decline in recent years due to the rise of online sales, it still plays a role in the overall market, particularly among smaller laboratories or academic institutions with less reliance on e-commerce. Retail sales allow for immediate procurement of essential supplies, catering to urgent needs in research settings. As the scientific community evolves, it may be necessary for retailers to adapt their strategies to integrate more digital solutions into their offerings.

Others:

Other distribution channels for cell culture instruments encompass various methods not categorized within direct, distributor, online, or retail sales. This may include partnerships with research institutions, collaborations with educational organizations, or government contracts that facilitate the acquisition of cell culture technologies. These alternative channels can help expand the market reach and accessibility of cell culture instruments across different sectors. Furthermore, the emergence of specialized vendors catering to niche applications or specific research areas is also contributing to this segment. As the demand for cell culture instruments continues to grow, exploring these alternative distribution channels can provide additional opportunities for manufacturers to penetrate new markets and enhance their customer base.

By Region

The regional analysis of the cell culture instrument sales market indicates that North America holds a dominant position, accounting for approximately 40% of the global market share. The region benefits from a robust healthcare infrastructure, a high concentration of research facilities, and significant investments in biotechnology and pharmaceutical research. The United States, in particular, is at the forefront of innovations in cell culture technologies, driven by the presence of leading manufacturers and academic institutions engaged in cutting-edge research. The North American market is expected to grow at a CAGR of 11.2% during the forecast period, fueled by the growing prevalence of chronic diseases and the increasing demand for personalized medicine.

Europe is the second largest market for cell culture instruments, contributing around 30% of the global share. The region is characterized by a strong emphasis on research and development, supported by favorable government policies and funding programs aimed at advancing healthcare and biotechnology sectors. Countries such as Germany, the United Kingdom, and France are leading players in the European market, driving innovations in cell culture technologies. The estimated CAGR for the European market is 9.8% from 2025 to 2035, as the demand for advanced cell culture solutions continues to rise in response to ongoing research initiatives and a growing biopharmaceutical landscape.

Opportunities

The cell culture instrument sales market presents numerous opportunities for growth, particularly due to the rapid advancements in biotechnology and pharmaceutical research. As researchers increasingly seek methods to enhance efficiency and accuracy in their experiments, there is a rising demand for innovative cell culture solutions that incorporate automation and real-time data analysis. The advent of advanced bioreactor systems and automated cell culture platforms is opening new avenues for researchers, enabling them to conduct high-throughput experiments and accelerate the drug development process. Furthermore, the ongoing exploration of personalized medicine is creating a surge in demand for customized cell culture technologies, tailored to meet the unique needs of individual patients. This trend is expected to drive significant investments in the development of specialized instruments and technologies that can support personalized therapeutic strategies.

Another promising opportunity in the cell culture instrument sales market is the increasing focus on sustainability and eco-friendly practices within research laboratories. As environmental concerns rise, researchers are seeking solutions that minimize waste and reduce the ecological impact of their experiments. This presents a chance for manufacturers to innovate and develop sustainable cell culture instruments that utilize renewable materials, reduce energy consumption, and implement waste reduction strategies. The integration of green technologies into cell culture practices not only aligns with global sustainability goals but also appeals to researchers committed to responsible scientific practices. By embracing these opportunities, companies can position themselves as leaders in a rapidly evolving market that values sustainability alongside innovation.

Threats

Despite the robust growth prospects in the cell culture instrument sales market, there are several threats that could hinder progress. One significant challenge is the increasing regulatory scrutiny surrounding the biopharmaceutical industry. As government agencies impose stricter regulations on the manufacturing and testing of biopharmaceutical products, the burden of compliance may slow down the pace of research and development. This could impact the demand for cell culture instruments, particularly among smaller laboratories that may struggle to meet these stringent requirements. Additionally, the high costs associated with advanced cell culture technologies may deter some research institutions from investing in the latest instruments, leading to a slowdown in market growth.

Another potential threat to the market is the rapid technological advancements that can lead to obsolescence. As new technologies emerge, manufacturers must continuously innovate to stay competitive and meet the evolving demands of researchers. Failure to keep pace with technological changes can result in outdated products that do not align with current research methodologies. Furthermore, the increasing prevalence of alternative methods in scientific research, such as organ-on-a-chip technologies and microfluidics, may draw attention away from traditional cell culture approaches. Companies that do not adapt to these shifts may face declining sales and market share, emphasizing the need for agility and forward-thinking strategies in an ever-changing landscape.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• Merck KGaA
• BD Biosciences
• GE Healthcare
• Corning Incorporated
• Lonza Group
• Sigma-Aldrich Corporation
• PerkinElmer Inc.
• Eppendorf AG
• Bio-Rad Laboratories Inc.
• New England Biolabs
• Gibco (part of Thermo Fisher Scientific)
• VWR International LLC (part of Avantor)
• Miltenyi Biotec
• Sartorius AG

The competitive landscape of the cell culture instrument sales market is characterized by numerous established players and several emerging companies striving to capture market share. Major companies are investing heavily in research and development to introduce innovative products and stay ahead of the competition. Strategic partnerships, mergers, and acquisitions are common in this space, as firms seek to expand their product portfolios and enhance their technological capabilities. Furthermore, companies are focusing on improving customer service and support, ensuring that researchers receive the necessary training and resources to maximize the potential of their cell culture instruments. This competitive environment fosters continuous innovation, pushing the boundaries of what is possible in cell culture research.

Thermo Fisher Scientific Inc. is one of the leading players in the cell culture instrument sales market, renowned for its extensive portfolio of laboratory products and solutions. The company offers a wide range of advanced cell culture instruments, including incubators, bioreactors, and automated cell culture systems. Thermo Fisher's commitment to innovation is evident through its continuous investment in research and development, which has led to the introduction of cutting-edge technologies that enhance the efficiency and throughput of cell culture processes. The company's strong presence in North America, combined with its global reach, positions it as a key player in the market, catering to the diverse needs of researchers across various sectors.

Merck KGaA is another prominent player in the cell culture instrument sales market, with a strong focus on providing high-quality products and solutions for life science research. The company's extensive portfolio includes a variety of cell culture media, supplements, and instruments designed to support researchers in their endeavors. Merck's commitment to sustainability and responsible research practices is reflected in its product offerings, which aim to minimize environmental impact while maximizing research outcomes. The company's strategic collaborations with academic institutions and research organizations further bolster its position in the market, enabling it to stay at the forefront of scientific advancements.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Lonza Group
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Eppendorf AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sartorius AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 GE Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 BD Biosciences
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Miltenyi Biotec
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 PerkinElmer Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 New England Biolabs
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Corning Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Sigma-Aldrich Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 VWR International LLC (part of Avantor)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Gibco (part of Thermo Fisher Scientific)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cell Culture Instrument Sales Market, By Application
    • 6.1.1 Cancer Research
    • 6.1.2 Drug Development
    • 6.1.3 Tissue Engineering
    • 6.1.4 Regenerative Medicine
    • 6.1.5 Stem Cell Research
  • 6.2 Cell Culture Instrument Sales Market, By Product Type
    • 6.2.1 Incubators
    • 6.2.2 Centrifuges
    • 6.2.3 Bioreactors
    • 6.2.4 Microscopes
    • 6.2.5 Pipetting Instruments
  • 6.3 Cell Culture Instrument Sales Market, By Distribution Channel
    • 6.3.1 Direct Sales
    • 6.3.2 Distributor Sales
    • 6.3.3 Online Sales
    • 6.3.4 Retail Sales
    • 6.3.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cell Culture Instrument Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cell Culture Instrument Sales market is categorized based on

By Product Type

• Incubators
• Centrifuges
• Bioreactors
• Microscopes
• Pipetting Instruments

By Application

• Cancer Research
• Drug Development
• Tissue Engineering
• Regenerative Medicine
• Stem Cell Research

By Distribution Channel

• Direct Sales
• Distributor Sales
• Online Sales
• Retail Sales
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• Merck KGaA
• BD Biosciences
• GE Healthcare
• Corning Incorporated
• Lonza Group
• Sigma-Aldrich Corporation
• PerkinElmer Inc.
• Eppendorf AG
• Bio-Rad Laboratories Inc.
• New England Biolabs
• Gibco (part of Thermo Fisher Scientific)
• VWR International LLC (part of Avantor)
• Miltenyi Biotec
• Sartorius AG